Increased prevalence of cardiovascular-kidney-metabolic syndrome during COVID-19: A propensity score-matched study
Authors' conclusion
Our findings indicate a substantial increase in the prevalence of CKM syndrome during the COVID-19 pandemic, with nearly half of the patients exhibiting one or more CKM syndrome components.
Study context
- Population
- Real-world population from a primary care database, followed 2017–202230,511 per period after matching
- Participants
- 81,051 participants
- Exposure
- Pandemic period vs pre-pandemic period
- Pre-pandemicn = 30,511reference
- Pandemicn = 30,511
- Outcome
- Prevalence of concurrent CKM syndrome components
Methodological detailsreal-world primary care database, closed cohort, 6-year follow-up (2017-2022), propensity-score matched for sex, age and BMI
- Real-world primary care database
- Closed cohort, 6-year follow-up (2017-2022)
- Propensity-score matched for sex, age and BMI
Main finding
As reported in the abstract
T2D diagnoses
Pre-pandemic
3554
events
Pandemic
7430
events
- Prediabetes: sharp rise
- 170%
Observational data: associations, not effects.
Further findings
Age-stratified analyses
- Higher burden of cardiovascular-kidney-metabolic (CKM) conditions with advancing age
Original publication
Increased prevalence of cardiovascular-kidney-metabolic syndrome during COVID-19: A propensity score-matched study. Diabetes Res Clin Pract. Published 12 November 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →